The Drug Enforcement Agency (DEA) is moving against cannabidiol (CBD), a supplement used to control pain and inflammation. The circumstances are extremely suspicious.Late last year, the DEA published a final rule that classifies marijuana and hemp extracts, including CBD, as Schedule 1 controlled substances—a category that includes heroin, LSD, mescaline, and MDMA. Note that none of the CBD extracts contains significant amounts of the psychoactive chemical in marijuana—only the non-psychoactive painkilling chemicals.
Please maintain access to CBD
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP][Your Email]